|1.||Sha, Xianyi: 3 articles (01/2013 - 06/2012)|
|2.||Fang, Xiaoling: 3 articles (01/2013 - 06/2012)|
|3.||Chen, Liangcen: 2 articles (01/2013 - 01/2013)|
|4.||Chen, Yanzuo: 2 articles (01/2013 - 01/2013)|
|5.||Ren, Qiuyue: 2 articles (01/2013 - 01/2013)|
|6.||Pitt, William G: 2 articles (12/2009 - 12/2005)|
|7.||Husseini, Ghaleb A: 2 articles (12/2009 - 12/2005)|
|8.||Zheng, Zubiao: 1 article (09/2014)|
|9.||Niu, Jiangxiu: 1 article (09/2014)|
|10.||Wang, Aidong: 1 article (09/2014)|
01/01/2013 - "The MTX-loaded Pluronic P105/F127 mixed micelle exhibited significant higher in vitro cytotoxicity in multidrug resistant tumor cells than that of control (MTX injection) mainly because of higher cellular uptake of MTX. "
06/01/2012 - "Considering other favorable characteristics, such as sustained PTX release in vitro, long-circulating time in vivo and increased PTX concentration in the tissues of ovaries and uterus in mice, the PCL-modified Pluronic P105 polymeric micelle system could have important clinical implications for delivery of paclitaxel and treatment of the resistant ovarian tumors."
06/01/2008 - "This work was designed to investigate a new micellar delivery system for in vitro reversal of resistant ovarian tumor cells, based on a nonionic triblock copolymer Pluronic P105 and paclitaxel (PTX). "
01/01/2013 - "Moreover, a much stronger antitumor efficacy in KBv tumor xenografts nude mice was observed in the MTX-loaded Pluronic P105/F127 mixed micelle group, than MTX. "
06/01/2008 - "The P105/PTX micelles were effectively able to reverse resistance to PTX in SKOV-3/PTX tumor cells compared with Taxol injection or free PTX solution, and the enhanced cytotoxicity in the resistant SKOV-3/PTX cell was related to the improved cellular uptake of PTX by Pluronic P105 copolymers."
|3.||Myeloid Leukemia (Leukemia, Myelocytic)
|5.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/01/2013 - "The aim of this work was to establish a novel polymeric mixed micelle composed of Pluronic P105 and F127 copolymers loaded with the poorly soluble antitumor drug docetaxel (DTX) against Taxol-resistant non-small cell lung cancer. "
01/01/2013 - "Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation."
|3.||Facilitative Glucose Transport Proteins (Glucose Transporter)
|4.||Folic Acid (Vitamin M)
|6.||UCON 50-HB-5100 (F127)
|8.||Polyethylene Glycols (Polyethylene Glycol)
|1.||Heterologous Transplantation (Xenotransplantation)